Nucleic acid lipid particle vaccine encapsulating HPV mRNA

Provided is a vaccine for preventing and/or treating infection caused by human papillomavirus. The lipid particles encapsulate nucleic acid capable of expressing human papillomavirus E6 and E7 antigens. The lipid contains a cationic lipid represented by general formula (Ia) or a pharmaceutically acc...

Full description

Saved in:
Bibliographic Details
Main Authors KOIZUMI, Makoto, NIWA, Takako, ISHII, Ken, SUZUKI, Takashi, JONAI, Nao, ONODERA, Yoshikuni, TAKESHITA, Fumihiko
Format Patent
LanguageEnglish
Published 30.06.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided is a vaccine for preventing and/or treating infection caused by human papillomavirus. The lipid particles encapsulate nucleic acid capable of expressing human papillomavirus E6 and E7 antigens. The lipid contains a cationic lipid represented by general formula (Ia) or a pharmaceutically acceptable salt thereof. In the formula, R
Bibliography:Application Number: AU20200382378